To include your compound in the COVID-19 Resource Center, submit it here.

Incara's heparin misses Phase II/III colitis endpoint

INCR said its deligoparin low molecular weight heparin failed to induce remission

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE